8th Eurasian Hematology Oncology Summit
How to Treat Newly Diagnosed AML in Unfit Patients: Pretreatment Testing, Intensive Therapy vs. Lower Intensity Therapy, FLT3/IDH-Mutated Options
By
8th Eurasian Hematology Oncology Summit
FEATURING
Tapan Kadia
By
8th Eurasian Hematology Oncology Summit
FEATURING
Tapan Kadia
Login to view comments.
Click here to Login